Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

2018 Pan Pacific Lymphoma Conference
B

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

By 2018 Pan Pacific Lymphoma Conference FEATURING Barbara Pro
By 2018 Pan Pacific Lymphoma Conference FEATURING Barbara Pro
256 views
October 2, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Hodgkin Lymphoma
20:26

Radiation Therapy for nondular lymphocyte predominant Hodgkin Lympho…

2018 Pan Pacific Lymphoma Conference

R. Hoppe

29 views
10:00

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

2018 Pan Pacific Lymphoma Conference

C. Moskowitz

57 views
15:48

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymp…

2018 Pan Pacific Lymphoma Conference

C. Moskowitz

38 views
21:11

Use of Total Metabolic Tumor Volume in PET Scans

2018 Pan Pacific Lymphoma Conference

N. Hansen

140 views
06:45

Hodgkin Lymphoma: First Relapse Options

2018 Pan Pacific Lymphoma Conference

B. Pro

87 views
16:04

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

2018 Pan Pacific Lymphoma Conference

B. Pro

256 views
20:54

Beyond Checkpoint Inhibitors for Hodgkin Lymphoma

2018 Pan Pacific Lymphoma Conference

S. Ansell

42 views
14:48

Hodgkin Lymphoma German Hodgkin Study Group Upfront Therapy

2018 Pan Pacific Lymphoma Conference

A. Engert

30 views